Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company daily Stock Chart
Eli Lilly and Company
IndexS&P 500 P/E25.12 EPS (ttm)4.40 Insider Own12.20% Shs Outstand962.90M Perf Week-2.86%
Market Cap106.42B Forward P/E16.55 EPS next Y6.68 Insider Trans-0.92% Shs Float962.90M Perf Month2.01%
Income4.34B PEG2.56 EPS next Q1.40 Inst Own82.60% Short Float1.19% Perf Quarter-4.73%
Sales23.23B P/S4.58 EPS this Y102.80% Inst Trans-1.35% Short Ratio2.82 Perf Half Y-9.76%
Book/sh3.02 P/B36.60 EPS next Y16.73% ROA19.00% Target Price123.83 Perf Year6.96%
Cash/sh2.46 P/C44.94 EPS next 5Y9.80% ROE111.40% 52W Range103.65 - 132.13 Perf YTD-4.49%
Dividend2.58 P/FCF73.66 EPS past 5Y-5.30% ROI14.70% 52W High-15.32% Beta0.17
Dividend %2.33% Quick Ratio0.90 Sales past 5Y1.20% Gross Margin76.70% 52W Low7.94% ATR2.80
Employees38680 Current Ratio1.10 Sales Q/Q0.90% Oper. Margin19.50% RSI (14)51.30 Volatility2.40% 2.47%
OptionableYes Debt/Eq5.68 EPS Q/Q738.50% Profit Margin33.80% Rel Volume0.36 Prev Close110.52
ShortableYes LT Debt/Eq4.93 EarningsJul 30 BMO Payout30.20% Avg Volume4.06M Price111.89
Recom2.50 SMA201.32% SMA500.23% SMA200-3.99% Volume172,423 Change1.24%
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-18-19 07:28AM  Better Buy: Eli Lilly vs. GlaxoSmithKline Motley Fool
Aug-16-19 04:25PM  How AbbVie Plans To Take On Pfizer, Lilly And Kick Its Humira Habit Investor's Business Daily
11:28AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY Zacks
09:19AM  Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe Zacks
Aug-15-19 03:36PM  The Top Pharma Stocks for 2019 Investopedia
10:30AM  Agios Rides High on Tibsovo Sales Amid Acute Competition Zacks
Aug-14-19 10:45AM  Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? Zacks
09:24AM  Lilly's Taltz Outshines J&J's Tremfya in Psoriasis Study Zacks
06:45AM  Lilly Launches Open Innovation Challenge to Help Transform Inflammatory Bowel Disease (IBD) Care through Digital Health PR Newswire
Aug-13-19 11:40AM  Lilly's Psoriasis Drug Found Superior To J&J's Tremfya In Phase 4 Study Benzinga
06:45AM  Lilly Announces Superiority of Taltz® (ixekizumab) versus TREMFYA® (guselkumab) in Delivering Total Skin Clearance at Week 12 in Topline Results from Head-to-Head (IXORA-R) Trial in People Living with Moderate to Severe Plaque Psoriasis PR Newswire
06:06AM  8 Stocks That Have Paid a Dividend for 125 (or More) Consecutive Years Motley Fool
06:00AM  How one Boston startup rode the diabetes investment wave to raise $126M American City Business Journals
Aug-11-19 07:02AM  Pharmaceutical groups should invest in public health systems Financial Times
12:16AM  US patients struggle to obtain Eli Lillys half-price insulin Financial Times
Aug-10-19 08:53AM  Dividend Investors: Don't Be Too Quick To Buy Eli Lilly and Company (NYSE:LLY) For Its Upcoming Dividend Simply Wall St.
Aug-09-19 08:05PM  Dicerna Pharmaceuticals Inc (DRNA) Q2 2019 Earnings Call Transcript Motley Fool
12:17PM  U.S. Court of Appeals Rules in Favor of Lilly in Alimta Alternate Salt Form Patent Lawsuit PR Newswire
11:11AM  Nektar (NKTR) Q2 Earnings Beat Estimates, Revenues Miss Zacks
10:59AM  Intrexon (XON) Reports Narrower-Than-Expected Loss in Q2 Zacks
09:50AM  Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Zacks
09:27AM  Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates Zacks
Aug-08-19 11:21AM  Top Stock Reports: Disney, Eli Lilly, ADP & More Zacks
10:54AM  Celldex (CLDX) Q2 Loss Narrower Than Expected, Revenues Miss Zacks
09:38AM  Radius (RDUS) Q2 Earnings Beat Estimates, Tymlos Sales Solid Zacks
09:00AM  Lilly Announces Positive Results for Emgality (galcanezumab) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments CNW Group
08:34AM  Teva (TEVA) Q2 Earnings, Sales Top Estimates, CFO Steps Down Zacks
07:39AM  UPDATE 1-Study shows Apple devices in combo with apps could identify dementia Reuters
06:45AM  Lilly, Evidation Health and Apple Study Shows Personal Digital Devices May Help in the Identification of Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia PR Newswire
Aug-07-19 04:31PM  Horizon Stock Pops On Beat And Raise As Another Drugmaker Reverses Investor's Business Daily
06:45AM  Lilly Announces Leadership Changes in Corporate Business Development, Oncology R&D, and Managed Healthcare Services PR Newswire
Aug-06-19 10:19AM  Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up Zacks
09:00AM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
Aug-05-19 10:46AM  Aduro (ADRO) Earnings Miss in Q2, Revenues Meet Estimates Zacks
09:18AM  Corcept's (CORT) Earnings & Revenues Miss Estimates in Q2 Zacks
09:15AM  Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio Zacks
07:54AM  Eli Lilly Announces Positive Results For Emgality Benzinga
06:45AM  Lilly Announces Positive Results for Emgality® (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments PR Newswire
Aug-04-19 03:04PM  3 Lung Cancer Stocks That Could Soar in September Motley Fool
Aug-02-19 09:54AM  Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger Zacks
Aug-01-19 09:42PM  Edited Transcript of LLY earnings conference call or presentation 30-Jul-19 1:00pm GMT Thomson Reuters StreetEvents
09:49AM  United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y Zacks
06:11AM  What Should Investors Know About Eli Lilly and Company's (NYSE:LLY) Growth? Simply Wall St.
02:00AM  FOCUS-Blue-blooded crabs at heart of pharma dispute on drug testing Reuters
Jul-31-19 05:15PM  Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates Benzinga
09:34AM  Amgen (AMGN) Q2 Earnings & Sales Beat, New Drugs Shine Zacks
Jul-30-19 11:24PM  Eli Lilly and Company (LLY) Q2 2019 Earnings Call Transcript Motley Fool
04:18PM  Why Pharma Giant Merck Expects Its Best Sales Growth In 9 Years Investor's Business Daily
03:00PM  Eli Lilly's Solid Q2 Results: What You'll Want to Know Motley Fool
01:14PM  Merck Shares Rise on Strong Sales Growth
01:06PM  Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y Zacks
01:04PM  Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up Zacks
12:10PM  6 Stock Gurus See Bargains Amid Market Highs Investopedia
10:53AM  Economic and Earnings Date Deluge Zacks
10:34AM  Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More Zacks
08:47AM  Eli Lilly tops profit estimates on boost from diabetes drugs Reuters
08:11AM  Eli Lilly lifts outlook after boost from diabetes drug Financial Times
08:02AM  Eli Lilly Reports Q2 Earnings Beat Benzinga
07:45AM  Eli Lilly (LLY) Tops Q2 Earnings Estimates Zacks
07:02AM  Eli Lilly Tops Q2 Profit Forecast, Lifts 2019 Guidance, as Trulicity Sales Surge
07:00AM  The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings Benzinga
06:59AM  UPDATE 3-Newer drugs help Eli Lilly top Wall Street quarterly profit estimate Reuters
06:42AM  Eli Lilly tops revenue estimates on diabetes drug boost Reuters
06:42AM  Eli Lilly's stock jumps after profit and revenue beats, raised guidance MarketWatch
06:25AM  Lilly Reports Second-Quarter 2019 Financial Results, Raises 2019 EPS Guidance PR Newswire
06:00AM  Lilly's Verzenio® (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2 PR Newswire
Jul-29-19 03:05PM  Pfizer to Combine Off-Patent Drug Business With Mylan
02:37PM  Q2 Earnings Preview For Eli Lilly Benzinga
10:38AM  Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up Zacks
10:12AM  What's in Store for Array BioPharma (ARRY) in Q4 Earnings? Zacks
09:32AM  Should You Buy Eli Lilly (LLY) Ahead of Earnings? Zacks
07:32AM  Is Eli Lilly (NYSE:LLY) A Risky Investment? Simply Wall St.
Jul-27-19 12:20PM  10 Biggest Cancer-Fighting Stocks Motley Fool
Jul-26-19 11:22AM  Senate advances bill to cut the cost of prescriptions Yahoo Finance Video
08:39AM  Pharma Stock Roundup: GSK, BMY Q2 Earnings, FDA Nod to LLY's Hypoglycemia Treatment Zacks
07:39AM  EMA panel recommends approving Bayer's cancer drug Vitrakvi Reuters
Jul-25-19 06:27PM  Eli Lilly (LLY) Stock Down 6.8% in 2019: Can Q2 Earnings Boost Performance? Zacks
07:21AM  The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug Benzinga
Jul-24-19 11:42PM  UPDATE 1-Eli Lilly's hypoglycemia treatment wins FDA approval Reuters
11:19PM  BAQSIMI (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA PR Newswire
06:24PM  Eli Lilly's hypoglycemia treatment wins FDA approval Reuters
09:04AM  Eli Lilly (LLY) to Report Q2 Earnings: What's in Store? Zacks
Jul-23-19 10:32AM  Earnings Preview: Eli Lilly (LLY) Q2 Earnings Expected to Decline Zacks
Jul-19-19 09:15AM  Eli Lilly (LLY) is a Top Dividend Stock Right Now: Should You Buy? Zacks
Jul-18-19 11:18AM  NuCana Initiates Dosing in Phase I Study for Solid Tumors Zacks
10:26AM  AC Immune Initiates Phase I Study for Alzheimer's Disease Zacks
Jul-17-19 07:00AM  AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer, an Investigational Treatment for Alzheimers Disease GlobeNewswire
Jul-16-19 09:51AM  Here's a Prescription for Eli Lilly Stock: Don't Swallow Yet
09:36AM  Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA Zacks
07:31AM  Jim Cramer Weighs In On Marvell, General Motors And More Benzinga
Jul-13-19 06:45AM  Lilly Presents New Findings on Stigma Faced by People with Migraine Based on Interim Results from the OVERCOME Observational Study PR Newswire
Jul-12-19 11:35AM  Drug Pricing Woes Linger on Repealing Drug Rebate Proposal Zacks
10:23AM  Health Care stocks help lead Wall Street rally Yahoo Finance Video
10:19AM  Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug Benzinga
08:00AM  Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine PR Newswire
06:45AM  AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality® (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine PR Newswire
Jul-11-19 04:22PM  Drug distributors surge, drug makers tumble after Trump administration reverses stance on rebates Yahoo Finance
03:00PM  4 Drug Stocks Getting Smashed InvestorPlace
12:58PM  4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal Zacks
10:58AM  The Zacks Analyst Blog Highlights: Bank of America, Eli Lilly, Boston Scientific, Schwab and Advanced Micro Devices Zacks
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; and Avidity Biosciences, Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smiley Joshua LSVP and CFOJul 15Buy108.4718520,06730,595Jul 15 03:46 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39404,036Jul 08 03:57 PM
Smiley Joshua LSVP and CFOJun 05Buy118.0342650,28130,410Jun 05 02:15 PM
Harrington Michael JSenior VP and General CounselJun 03Sale116.7216,0001,867,520110,300Jun 04 01:57 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 03Sale117.147,577887,5700May 07 02:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:04 PM
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM
LILLY ENDOWMENT INC10% OwnerMar 26Sale131.41205,00026,938,688116,810,304Mar 27 02:57 PM
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM
LILLY ENDOWMENT INC10% OwnerFeb 28Sale126.73200,00025,345,017117,225,304Mar 01 01:25 PM
LILLY ENDOWMENT INC10% OwnerFeb 22Sale124.19195,00024,217,635117,425,304Feb 25 04:06 PM
LILLY ENDOWMENT INC10% OwnerFeb 19Sale122.48205,00025,108,513117,620,304Feb 20 01:35 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048082Feb 20 03:52 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 15Sale121.0025,0003,025,000132,962Feb 20 03:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.003,221054,175Feb 06 08:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.009,722050,946Feb 05 07:09 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0012,2220131,708Feb 05 07:04 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0012,7780102,548Feb 05 06:59 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.008,8890109,100Feb 05 06:55 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0012,2220136,756Feb 05 06:49 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.003,333020,901Feb 05 06:43 PM
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM